Curtis Rambaran

Curtis Rambaran has extensive experience working in the field of cardiovascular medicine and drug development. In their current role as Chief Medical Officer at Silence Therapeutics plc, Curtis oversees clinical sciences and holds the title of Senior Vice President. Prior to this, Curtis held leadership positions at Daiichi Sankyo and GlaxoSmithKline, where Curtis led various cardiovascular clinical development studies. With a background in medicine and a postgraduate research doctorate in cardiovascular medicine, Curtis has a strong foundation in the healthcare industry.